Literature DB >> 25086988

Development and characterization of salivary adenoid cystic carcinoma cell line.

Jie Li1, Laszlo Perlaky2, Pulivarthi Rao2, Randal S Weber3, Adel K El-Naggar4.   

Abstract

OBJECTIVE: To develop in vitro adenoid cystic carcinoma cell line as a surrogate for functional studies.
MATERIALS AND METHODS: Cells obtained from a primary ACC of the base of tongue were cultivated in vitro and immortalized with h-TERT. Morphologic, cytogenetic and functional studies were performed.
RESULTS: Tumor cells were verified by positive reactions to keratin and smooth muscle actin and phenotypic cellular and nuclear features. In-vitro cell growth and colony formation assay supported their tumor nature.
CONCLUSION: We authenticated an ACC cell line with hybrid epithelial-myoepithelial feature as a resource for functional experimentation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Cell line; Salivary gland tumors

Mesh：

Substances：

Year:  2014        PMID： 25086988      PMCID： PMC4573592          DOI： 10.1016/j.oraloncology.2014.06.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


  39 in total

1.  Changes of histological and biological features by serial passages in a human adenoid cystic carcinoma line transplantable in nude mice.

Authors:  Susumu Hashitani; Kazuma Noguchi; Yukiyo Manno; Kuniyasu Moridera; Kazuki Takaoka; Norihiko Nishimura; Hiromitsu Kishimoto; Kazunari Sakurai; Masahiro Urade
Journal:  Oncol Rep       Date:  2005-04       Impact factor: 3.906

2.  Establishment and characterization of a human adenoid cystic carcinoma line of the salivary gland which is serially transplantable and spontaneously metastasises to the lung in nude mice.

Authors:  M Umeda; H Komatsubara; N Nishimatsu; N Oku; Y Shibuya; S Yokoo; T Komori
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

3.  Widespread intraspecies cross-contamination of human tumor cell lines arising at source.

Authors:  R A MacLeod; W G Dirks; Y Matsuo; M Kaufmann; H Milch; H G Drexler
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

4.  Establishment of nude mouse transplantable model of a human adenoid cystic carcinoma of the oral floor showing metastasis to the lymph node and lung.

Authors:  Susumu Hashitani; Masahiro Urade; Yusuke Zushi; Emi Segawa; Shin Okui; Kazunari Sakurai
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

5.  Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.

Authors:  Youcheng Yu; Wantao Chen; Yuexing Zhang; Anne W Hamburger; Hongya Pan; Zhiyuan Zhang
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

6.  Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

Authors:  M J Bissell; P A Kenny; D C Radisky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

7.  Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.

Authors:  Samuel L Volchenboum; Cheng Li; Shuli Li; Edward F Attiyeh; C Patrick Reynolds; John M Maris; A Thomas Look; Rani E George
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

8.  The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids.

Authors:  P C De Witt Hamer; A A G Van Tilborg; P P Eijk; P Sminia; D Troost; C J F Van Noorden; B Ylstra; S Leenstra
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

Review 9.  Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Authors:  Sanford H Barsky; Nina J Karlin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.698

10.  Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.

Authors:  Janyaporn Phuchareon; Yoshihito Ohta; Jonathan M Woo; David W Eisele; Osamu Tetsu
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240
View more
  14 in total

1.  Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.

Authors:  Diana Bell; Renata Ferrarotto; Melanie D Fox; Dianna Roberts; Ehab Y Hanna; Randal S Weber; Adel K El-Naggar
Journal:  Cancer Biol Ther       Date:  2015-04-29       Impact factor: 4.742

2.  UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.

Authors:  Kristy A Warner; Alexandra E Oklejas; Alexander T Pearson; Zhaocheng Zhang; Weishing Wu; Vasu Divi; Christie Rodriguez-Ramirez; Rogerio M Castilho; Peter J Polverini; Jacques E Nör
Journal:  Oral Oncol       Date:  2018-10-18       Impact factor: 5.337

3.  Establishment and genomic characterization of primary salivary duct carcinoma cell line.

Authors:  Jie Li; Yohitsugu Mitani; Pulivarthi H Rao; Laszlo Perlaky; Bin Liu; Randal S Weber; Adel K El-Naggar
Journal:  Oral Oncol       Date:  2017-05-02       Impact factor: 5.337

4.  Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.

Authors:  Teresa Savarese; Andrea Abate; Sandra Sigala; Paolo Bossi; Ram Manohar Basnet; Luigi Lorini; Cristina Gurizzan; Michele Tomasoni; Davide Lombardi; Davide Tomasini; Daniela Zizioli; Maurizio Memo; Alfredo Berruti; Sara A Bonini
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 5.  Systemic therapies for salivary gland adenoid cystic carcinoma.

Authors:  Sosuke Sahara; Alexandra E Herzog; Jacques E Nör
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

6.  Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.

Authors:  Kristy A Warner; Felipe Nör; Gerson A Acasigua; Manoela D Martins; Zhaocheng Zhang; Scott A McLean; Matthew E Spector; Douglas B Chepeha; Joseph Helman; Michael J Wick; Christopher A Moskaluk; Rogerio M Castilho; Alexander T Pearson; Shaomeng Wang; Jacques E Nör
Journal:  Clin Cancer Res       Date:  2016-03-02       Impact factor: 12.531

7.  Down-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway.

Authors:  Yancan Liang; Jiantao Ye; Jiuyang Jiao; Jin Zhang; Yingjuan Lu; Li Zhang; Di Wan; Liming Duan; You Wu; Bin Zhang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 8.  Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.

Authors:  Young Kwang Chae; Su Yun Chung; Andrew A Davis; Benedito A Carneiro; Sunandana Chandra; Jason Kaplan; Aparna Kalyan; Francis J Giles
Journal:  Oncotarget       Date:  2015-11-10

Review 9.  Adenoid cystic carcinoma: emerging role of translocations and gene fusions.

Authors:  Piotr T Wysocki; Evgeny Izumchenko; Juliet Meir; Patrick K Ha; David Sidransky; Mariana Brait
Journal:  Oncotarget       Date:  2016-10-04

10.  A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.

Authors:  Chen Chen; Sujata Choudhury; Darawalee Wangsa; Chamille J Lescott; Devan J Wilkins; Praathibha Sripadhan; Xuefeng Liu; Danny Wangsa; Thomas Ried; Christopher Moskaluk; Michael J Wick; Eric Glasgow; Richard Schlegel; Seema Agarwal
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.